We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sweet Syndrome Following SARS-CoV2 Vaccination.
- Authors
Baffa, Maria Efenesia; Maglie, Roberto; Giovannozzi, Neri; Montefusco, Francesca; Senatore, Stefano; Massi, Daniela; Antiga, Emiliano
- Abstract
Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet's syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet's syndrome in this case.
- Subjects
BIONTECH SE; PFIZER Inc.; SARS-CoV-2; SWEET'S syndrome; COVID-19 pandemic; VACCINATION; COVID-19 vaccines
- Publication
Vaccines, 2021, Vol 9, Issue 11, p1212
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines9111212